Epigenetic modifications in pancreas development, diabetes, and therapeutics.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 3, p. 1343, doi. 10.1002/med.21878
- By:
- Publication type:
- Article
Works matching IS 01986325 AND DT 2022 AND VI 42 AND IP 3
Results: 12
1
2
Strategies for designing proteolysis targeting chimaeras (PROTACs).
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 3, p. 1280, doi. 10.1002/med.21877
- By:
- Publication type:
- Article
3
Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 3, p. 1246, doi. 10.1002/med.21876
- By:
- Publication type:
- Article
4
Cardiovascular therapeutics: A new potential for anxiety treatment?
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 3, p. 1202, doi. 10.1002/med.21875
- By:
- Publication type:
- Article
5
β3‐Adrenoceptor, a novel player in the round‐trip from neonatal diseases to cancer: Suggestive clues from embryo.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 3, p. 1179, doi. 10.1002/med.21874
- By:
- Publication type:
- Article
6
Advances in ameliorating inflammatory diseases and cancers by andrographolide: Pharmacokinetics, pharmacodynamics, and perspective.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 3, p. 1147, doi. 10.1002/med.21873
- By:
- Publication type:
- Article
7
Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 3, p. 1111, doi. 10.1002/med.21872
- By:
- Publication type:
- Article
8
Recent advances in the development of allosteric protein tyrosine phosphatase inhibitors for drug discovery.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 3, p. 1064, doi. 10.1002/med.21871
- By:
- Publication type:
- Article
9
Salinomycin as a potent anticancer stem cell agent: State of the art and future directions.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 3, p. 1037, doi. 10.1002/med.21870
- By:
- Publication type:
- Article
10
Role of membrane proteins in bacterial resistance to antimicrobial peptides.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 3, p. 1023, doi. 10.1002/med.21869
- By:
- Publication type:
- Article
11
Front Cover Image, Volume 42, Issue 3.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 3, p. i, doi. 10.1002/med.21827
- By:
- Publication type:
- Article
12
Issue Information.
- Published in:
- Medicinal Research Reviews, 2022, v. 42, n. 3, p. 1019, doi. 10.1002/med.21825
- Publication type:
- Article